Working… Menu
Trial record 1 of 7 for:    stemedica
Previous Study | Return to List | Next Study

Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02833792
Recruitment Status : Recruiting
First Posted : July 14, 2016
Last Update Posted : October 29, 2020
Stemedica International SA
Information provided by (Responsible Party):
Stemedica Cell Technologies, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2022
Estimated Study Completion Date : June 2023